217 related articles for article (PubMed ID: 28751103)
1. [Prevalence and characterization of overactive bladder detected in a population in Madrid with self-administered OAB-V3 questionnaire in Primary Care].
Angulo JC; Calderín MP; Fernández Y; González M; Gómez E; Herreros MB; Peñasco P; Zapatero M; Dorado JF
Aten Primaria; 2018 Feb; 50(2):79-87. PubMed ID: 28751103
[TBL] [Abstract][Full Text] [Related]
2. [Psychometric validation of the OAB-V8 and OAB-V3 scales for the screening of patients with probable overactive bladder in the Spanish population].
Brenes FJ; Angulo JC; Ochayta D; Rejas J; Arumí D; Cañadas A; Lizarraga I
Med Clin (Barc); 2014 Dec; 143(12):521-9. PubMed ID: 24725856
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the B-SAQ, OAB-V8 and OAB-V3 questionnaires as screening tools for overactive bladders in clinical practice.
Angulo JC; Calderín MP; Fernández Y; González M; Gómez E; Herreros MB; Peñasco P; Zapatero M; Dorado JF
Actas Urol Esp; 2017; 41(6):383-390. PubMed ID: 28268078
[TBL] [Abstract][Full Text] [Related]
4. Assessment of female prevalence of overactive bladder (OAB) in Barcelona using a self-administered screening questionnaire: the Cuestionario de Autoevaluación del Control de la Vejiga (CACV).
Lugo Salcedo F; Sánchez Borrego R;
Int Urogynecol J; 2013 Sep; 24(9):1559-66. PubMed ID: 23443344
[TBL] [Abstract][Full Text] [Related]
5. Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder?
Bunyavejchevin S; Liao L; Lu SH; Choo MS; Rabbani KJ; Havanond P
J Obstet Gynaecol Res; 2015 Aug; 41(8):1260-5. PubMed ID: 26081949
[TBL] [Abstract][Full Text] [Related]
6. Impact of daily number of urgency urinary incontinence episodes on overactive bladder patient reported outcomes.
Angulo JC; Brenes FJ; Lizarraga I; Rejas J; Trillo S; Ochayta D; Arumi D
Actas Urol Esp; 2016 Apr; 40(3):173-82. PubMed ID: 26811022
[TBL] [Abstract][Full Text] [Related]
7. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
8. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
9. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form.
Arlandis S; Ruiz MA; Errando C; Villacampa F; Arumí D; Lizarraga I; Rejas J
Clin Drug Investig; 2012 Aug; 32(8):523-32. PubMed ID: 22741748
[TBL] [Abstract][Full Text] [Related]
11. Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool.
Villacampa F; Ruiz MA; Errando C; Arlandis S; Arumí D; Lizarraga I; Rejas J
Int Urogynecol J; 2013 Apr; 24(4):573-81. PubMed ID: 23111865
[TBL] [Abstract][Full Text] [Related]
12. The Prevalence of Overactive Bladder Symptoms in Women in Algeria, Egypt, Jordan and Lebanon: A Cross-Sectional Population-Based Survey.
Al Edwan G; Abdelazim MS; Salhab SE; Jamal YM; Soliman MA
Adv Ther; 2021 Feb; 38(2):1155-1167. PubMed ID: 33354738
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.
Chuang YC; Liu SP; Lee KS; Liao L; Wang J; Yoo TK; Chu R; Sumarsono B
Low Urin Tract Symptoms; 2019 Jan; 11(1):48-55. PubMed ID: 28967230
[TBL] [Abstract][Full Text] [Related]
14. Impact of overactive bladder symptoms on work activity: The ACTIVHA study.
Rapariz M; Mora AM; Roset M
Actas Urol Esp (Engl Ed); 2018 Apr; 42(3):176-184. PubMed ID: 29103735
[TBL] [Abstract][Full Text] [Related]
15. Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*.
Herschorn S; Heesakkers J; Castro-Diaz D; Wang JT; Brodsky M; Guan Z;
Curr Med Res Opin; 2008 Dec; 24(12):3513-21. PubMed ID: 19032133
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, beliefs, and coping strategies among older patients with overactive bladder.
Blasco P; Valdivia MI; Oña MR; Roset M; Mora AM; Hernández M
Neurourol Urodyn; 2017 Mar; 36(3):774-779. PubMed ID: 27120009
[TBL] [Abstract][Full Text] [Related]
17. Cultural adaptation to Spanish (Spain) of the "Overactive Bladder - Family Impact Measure (OAB-FIM)" questionnaire.
Arlandis Guzmán S; Martínez Cuenca E; Martínez García R; Bonillo García MA; Rejas J; Broseta-Rico E
Actas Urol Esp; 2017 Jun; 41(5):324-332. PubMed ID: 28202287
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
Herschorn S; Staskin D; Tu LM; Fialkov J; Walsh T; Gooch K; Schermer CR
Health Qual Life Outcomes; 2018 Apr; 16(1):69. PubMed ID: 29673355
[TBL] [Abstract][Full Text] [Related]
19. Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS).
Lee KS; Choo MS; Seo JT; Oh SJ; Kim HG; Ng K; Lee KJ; Tan JT; Kim JC
Health Qual Life Outcomes; 2015 Jun; 13():89. PubMed ID: 26113125
[TBL] [Abstract][Full Text] [Related]
20. The effect of hyperactive bladder severity on healthcare utilization and labor productivity.
Angulo JC; Brenes FJ; Ochayta D; Lizarraga I; Arumí D; Trillo S; Rejas J
Actas Urol Esp; 2014 May; 38(4):249-56. PubMed ID: 24462234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
